Green Cross Holdings Corporation (KRX: 005250)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,800
-640 (-3.67%)
Dec 20, 2024, 3:30 PM KST
7.69%
Market Cap 762.75B
Revenue (ttm) 2.18T
Net Income (ttm) -67.89B
Shares Out 45.40M
EPS (ttm) -1,495.35
PE Ratio n/a
Forward PE n/a
Dividend 300.00 (1.79%)
Ex-Dividend Date Dec 27, 2024
Volume 126,082
Open 17,270
Previous Close 17,440
Day's Range 16,800 - 17,340
52-Week Range 12,940 - 18,490
Beta 0.85
Analysts n/a
Price Target n/a
Earnings Date Feb 13, 2025

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1967
Employees 151
Stock Exchange Korea Stock Exchange
Ticker Symbol 005250
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.